Clinical Analysis of the Renal Protective Effect of GLP-1 on Diabetic Patients Based on Edge Detection.

Wang, Jing; Wang, Yang; Pang, Ping; Jia, Xiaomeng; Yan, Xu; Lv, Zhaohui

Wang, Jing; Wang, Yang; Pang, Ping; Jia, Xiaomeng; Yan, Xu; Lv, Zhaohui.

Afiliação

Wang J; Department of Clinical Nutrition, The 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
Wang Y; Department of Nephrology, The 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
Pang P; Department of Endocrinology, Hainan Branch of Chinese PLA General Hospital, Sanya 572013, China.
Jia X; Center for Endocrine Metabolism and Immune Disease, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China.
Yan X; Department of Clinical Nutrition, The 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
Lv Z; Department of Endocrinology, The 1st Medical Center of Chinese PLA General Hospital, Beijing 100853, China.

J Healthc Eng ; 2022: 6504006, 2022.

Article em En | MEDLINE | ID: mdl-35360475

Assuntos

Diabetes Mellitus; Peptídeo 1 Semelhante ao Glucagon; Atenção à Saúde; Humanos; Rim/fisiologia; Leucócitos Mononucleares

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Healthc Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google